(Q86551661)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23563237%20AND%20SRC:MED&resulttype=core&format=json

28 February 2020

title

STAT3 mutations are frequent in CD30+ T-cell lymphomas and T-cell large granular lymphocytic leukemia (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23563237%20AND%20SRC:MED&resulttype=core&format=json

28 February 2020

R S Ohgami

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23563237%20AND%20SRC:MED&resulttype=core&format=json

28 February 2020

L Ma

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23563237%20AND%20SRC:MED&resulttype=core&format=json

28 February 2020

J D Merker

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23563237%20AND%20SRC:MED&resulttype=core&format=json

28 February 2020

B Martinez

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23563237%20AND%20SRC:MED&resulttype=core&format=json

28 February 2020

J L Zehnder

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23563237%20AND%20SRC:MED&resulttype=core&format=json

28 February 2020

D A Arber

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23563237%20AND%20SRC:MED&resulttype=core&format=json

28 February 2020

publication date

8 April 2013

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23563237%20AND%20SRC:MED&resulttype=core&format=json

28 February 2020

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23563237%20AND%20SRC:MED&resulttype=core&format=json

28 February 2020

volume

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23563237%20AND%20SRC:MED&resulttype=core&format=json

28 February 2020

issue

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23563237%20AND%20SRC:MED&resulttype=core&format=json

28 February 2020

page(s)

2244-2247

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23563237%20AND%20SRC:MED&resulttype=core&format=json

STAT3: a multifaceted oncogene

28 February 2020

cites work

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2013.104

7 January 2021

Dominant-negative mutations in the DNA-binding domain of STAT3 cause hyper-IgE syndrome

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2013.104

7 January 2021

Somatic STAT3 mutations in large granular lymphocytic leukemia

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2013.104

7 January 2021

STAT3 mutations unify the pathogenesis of chronic lymphoproliferative disorders of NK cells and T-cell large granular lymphocyte leukemia

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2013.104

7 January 2021

Constitutive STAT3-activation in Sezary syndrome: tyrphostin AG490 inhibits STAT3-activation, interleukin-2 receptor expression and growth of leukemic Sezary cells

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2013.104

7 January 2021

Refining the diagnosis of T-cell large granular lymphocytic leukemia by combining distinct patterns of antigen expression with T-cell clonality studies

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2013.104

7 January 2021

Stat3 is required for ALK-mediated lymphomagenesis and provides a possible therapeutic target

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2013.104

7 January 2021

Targeting Stat3 in cancer therapy

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2013.104

7 January 2021